<html>
<head>PUBMED IDs for EXTL2</head>
<body bgcolor='#C5F0F2'><h1>EXTL2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9450183/'>Identification and characterization of a novel member of the EXT gene family, EXTL2.</a> February 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9479495/'>Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family.</a> February 28  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10318803/'>The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate.</a> May 13  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10480354/'>Mutation analysis of hereditary multiple exostoses in the Chinese.</a> September 10  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10878610/'>EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.</a> July 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10965119/'>Characterization and genomic localization of the mouse Extl2 gene.</a> August 31  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11121397/'>rib-2, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes encodes a novel alpha1,4-N-acetylglucosaminyltransferase involved in the biosynthetic initiation and elongation of heparan sulfate.</a> December 21  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11390981/'>Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.</a> June 8  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12562774/'>Crystal structure of an alpha 1,4-N-acetylhexosaminyltransferase (EXTL2), a member of the exostosin gene family involved in heparan sulfate biosynthesis.</a> February 4  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14571142/'>Elucidation of correspondence between swine chromosome 4 and human chromosome 1 by assigning 27 genes to the ImpRH map, and development of microsatellites in the proximity of 14 genes.</a> October 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16778156/'>The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I.</a> June 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17237233/'>Expression of rib-1, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes, is indispensable for heparan sulfate synthesis and embryonic morphogenesis.</a> January 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17761672/'>Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.</a> September 1  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17980567/'>Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18463796/'>Hydrogen peroxide as a potential mediator of the transcriptional regulation of heparan sulphate biosynthesis in keratinocytes.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19690583/'>Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses.</a> February 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20377530/'>Biosynthesis of heparan sulfate in EXT1-deficient cells.</a> July 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23395820/'>EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner.</a> June 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23734945/'>Roles of EXTL2, a member of the EXT family of tumour suppressors, in liver injury and regeneration processes.</a> October 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23734882/'>Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24176719/'>EXTL2 controls liver regeneration and aortic calcification through xylose kinase-dependent regulation of glycosaminoglycan biosynthesis.</a> January 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25829497/'>Reduced Expression of EXTL2, a Member of the Exostosin (EXT) Family of Glycosyltransferases, in Human Embryonic Kidney 293 Cells Results in Longer Heparan Sulfate Chains.</a> September 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26347037/'>EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome.</a> August 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26347032/'>Genomics: Adding another dimension to gene regulation.</a> December 15  2015<br></body></html>
